Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BIMI International Medical Inc. (BIMI)
USD0.00
+0.00 (+0.00%)
CN OTC Healthcare Medical - Pharmaceuticals
Address
Chongqing Corporation Avenue 400010
Chongqing, CN
Chongqing, CN
CEO
Tiewei Song
Website
usbimi.com/index.html
IPO
2006-10-18
CIK 1213660 ISIN US05552Q3011
Description
BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products. Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region. The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.00
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
790
Beta
-0.58
Float Shares
11.59M
Free Float %
100.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -66.67% | -99.89% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-3.54
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%-44.5% Q3'23: -65.5% (vs Q3'22)
-
EPS growth Medical - Pharmaceuticals: +20.2%+87.1% ★ Q3'23: +69.4% (vs Q3'22)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%-161.0% Q3'23: -82.7% (vs Q3'22)
-
EBIT margin Medical - Pharmaceuticals: +6.8%-153.8% Q3'23: -122.8% (vs Q3'22)
-
ROIC Medical - Pharmaceuticals: +6.1%-218.2% Q3'23: -91.0% (vs Q3'22)
-
Share dilution Medical - Pharmaceuticals: +0.0%+396.9% Q3'23: +76.6% (vs Q3'22)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×-0.30× Q3'23: -0.36× (vs Q3'22)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-15.08M
OE per share TTM
-4.51
Owner's Yield
-2,345,063.45%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
110.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Energy”) | 19.05M | 47.78% | 19.05M | — | 19.05M | 10.00 | CO | Republic of China | 2009-06-18 | ↗ |
| 2 | Li | 19.05M | 47.78% | — | 19.05M | — | 10.00 | IN | Republic of China | 2009-06-18 | ↗ |
| 3 | Wang | 19.05M | 47.78% | — | 19.05M | — | 10.00 | IN | Republic of China | 2009-06-18 | ↗ |
| 4 | Fnu Oudom | 12.50M | 44.09% | 12.50M | — | 12.50M | — | IN | Vanuatu | 2022-08-08 | ↗ |
| 5 | I.D. No. | 3.32M | 8.33% | 3.32M | — | 3.32M | — | CO | Virgin Islands | 2008-04-30 | ↗ |
| 6 | No. | 3.32M | 8.33% | 3.32M | — | 3.32M | — | CO | Virgin Islands | 2008-04-30 | ↗ |
| 7 | Hudson Bay Capital Management LP | 1.92M | 4.99% | — | 1.92M | — | — | PN | State of Delaware | 2022-03-03 | ↗ |
| 8 | Sander Gerber | 1.92M | 4.99% | — | 1.92M | — | — | IN | State of Delaware | 2022-03-03 | ↗ |
| 9 | Bi | 1.50M | 19.80% | 1.50M | 1.50M | 1.50M | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 10 | Song | 1.34M | 4.72% | 1.34M | — | 1.34M | — | IN | Republic of China | 2022-08-02 | ↗ |
| 11 | South World Ltd. | 607.6K | 4.57% | — | — | — | 10.00 | CO | Virgin Islands | 2009-12-23 | ↗ |
| 12 | JIANG | 357.6K | 4.72% | 357.6K | 357.6K | 357.6K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 13 | XIA | 323.3K | 4.27% | 323.3K | 323.3K | 323.3K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 14 | GUAN | 280.3K | 3.70% | 280.3K | 280.3K | 280.3K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 15 | ZHANG | 260.8K | 3.44% | 260.8K | 260.8K | 260.8K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 16 | HE | 256.7K | 3.39% | 256.7K | 256.7K | 256.7K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 17 | SHEN | 221.6K | 2.93% | 221.6K | 221.6K | 221.6K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 18 | LIU | 205.1K | 2.71% | 205.1K | 205.1K | 205.1K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
| 19 | YU | 200.1K | 2.64% | 200.1K | 200.1K | 200.1K | 10.00 | IN | Republic of China | 2019-01-15 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
1.12M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,123,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | Oudom Fnu | Director / 10% Owner | A-Award | A | Common Stock | 1,123,500 | 0.00 | 1.1K | 1,518,243 | — | ↗ |
| 2024-02-28 | Tiewei Song | Director / Officer | S-Sale | D | Common Stock | 4,000 | 4.08 | 16.3K | 337,117 | — | ↗ |
| 2024-02-26 | Tiewei Song | Director / Officer | S-Sale | D | Common Stock | 724 | 4.01 | 2.9K | 341,117 | — | ↗ |
| 2024-01-02 | Oudom Fnu | Director / 10% Owner | A-Award | A | Common Stock | 2,000,000 | 1.50 | 3.00M | 10,264,044 | — | ↗ |
| 2023-12-29 | Smith Symington Wei | Director | — | D | Common Stock | 0 | 0.00 | — | 3,456 | — | ↗ |
| 2023-12-28 | Oudom Fnu | Director / 10% Owner | A-Award | A | Common Stock | 214,044 | 1.20 | 256.9K | 8,264,044 | — | ↗ |
| 2023-12-06 | Oudom Fnu | Director / 10% Owner | J-Other | A | Common Stock | 5,000,000 | 0.00 | — | 7,850,000 | — | ↗ |
| 2023-06-19 | Oudom Fnu | Director / 10% Owner | A-Award | A | Common Stock | 270,000 | 6.00 | 1.62M | 2,850,000 | — | ↗ |
| 2022-07-19 | Oudom Fnu | Officer | A-Award | A | Common Stock | 12,500,000 | 0.40 | 5.00M | 12,500,000 | — | ↗ |
| 2022-07-18 | Tiewei Song | Officer | A-Award | A | Common Stock | 124,427 | 58,817.00 | 7.32B | 1,124,427 | — | ↗ |
| 2022-05-12 | Ang Sammi Ean Seok | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-05-09 | Oudom Fnu | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-15 | Wang Xiaoping | Director | — | D | common stock | 0 | 0.00 | — | 500,000 | — | ↗ |
| 2021-05-21 | Zhong Baiqun | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-02-17 | Tingting Zhang | Director / Officer | — | D | Common stock, $0.001 par value | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-05-18 | Tiewei Song | Director | — | D | Common stock, $0.001 par value | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-04-09 | LIHUA WANG | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200,000 | 1.44 | 288.0K | 474,852 | — | ↗ |
| 2018-04-09 | GANG LI | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 800,000 | 1.40 | 1.12M | 1,899,409 | — | ↗ |
| 2018-04-09 | Bi Yongquan | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,500,000 | — | ↗ |
| 2015-05-07 | LIHUA WANG | Director / Officer / 10% Owner | J-Other | A | Common Stock | 166,828 | 2.06 | 343.7K | 674,852 | — | ↗ |
| 2015-05-07 | GANG LI | Director / Officer / 10% Owner | J-Other | A | Common Stock | 667,314 | 2.06 | 1.37M | 2,699,409 | — | ↗ |
| 2014-08-28 | Psomiadis Themistocles | Director | S-Sale | A | Common Stock | 19,925 | 1.00 | 19.8K | 1,439,814 | — | ↗ |
| 2014-08-26 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 19,925 | 1.06 | 21.1K | 1,409,889 | — | ↗ |
| 2014-08-25 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 3,425 | 1.21 | 4.1K | 1,429,814 | — | ↗ |
| 2014-08-21 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 13,500 | 1.25 | 16.8K | 1,433,239 | — | ↗ |
| 2014-08-13 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 10,000 | 1.34 | 13.4K | 4,121,113 | — | ↗ |
| 2014-08-11 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 8,500 | 1.31 | 11.1K | 4,131,113 | — | ↗ |
| 2014-08-05 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 27,900 | 1.28 | 35.8K | 4,139,613 | — | ↗ |
| 2014-08-04 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 7,900 | 1.24 | 9.8K | 4,167,513 | — | ↗ |
| 2014-08-01 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 13,750 | 1.29 | 17.7K | 4,175,413 | — | ↗ |
| 2014-07-23 | Psomiadis Themistocles | Director | S-Sale | A | Common Stock | 400 | 1.18 | 472.00 | 1,446,739 | — | ↗ |
| 2014-07-23 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 2,000 | 1.48 | 3.0K | 4,189,163 | — | ↗ |
| 2014-07-22 | Psomiadis Themistocles | Director | S-Sale | A | Common Stock | 1,250 | 1.48 | 1.9K | 1,446,339 | — | ↗ |
| 2014-07-21 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 1,000 | 1.15 | 1.2K | 1,445,089 | — | ↗ |
| 2014-07-18 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | common stock | 1,500 | 1.20 | 1.8K | 4,191,163 | — | ↗ |
| 2014-07-03 | Psomiadis Themistocles | Director | J-Other | D | Common Stock | 125,000 | 0.00 | — | 1,465,289 | — | ↗ |
| 2014-07-02 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 500 | 1.30 | 650.00 | 1,464,789 | — | ↗ |
| 2014-05-30 | NOVIELLI MICHAEL A | Director / 10% Owner | S-Sale | D | COMMON STOCK | 2,325 | 1.50 | 3.5K | 4,192,663 | — | ↗ |
| 2014-05-29 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 6,000 | 1.35 | 8.1K | 1,601,489 | — | ↗ |
| 2014-05-20 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 2,202 | 1.02 | 2.2K | 1,614,197 | — | ↗ |
| 2014-05-20 | NOVIELLI MICHAEL A | Director | S-Sale | D | Common Stock | 10,000 | 0.98 | 9.8K | 4,194,988 | — | ↗ |
| 2014-05-19 | Psomiadis Themistocles | Director | S-Sale | A | Common Stock | 500 | 1.05 | 525.00 | 1,615,900 | — | ↗ |
| 2014-05-19 | NOVIELLI MICHAEL A | Director | S-Sale | D | Common Stock | 10,000 | 1.03 | 10.3K | 4,194,988 | — | ↗ |
| 2014-05-16 | Psomiadis Themistocles | Director | S-Sale | D | Common Stock | 23,000 | 1.00 | 23.0K | 1,616,900 | — | ↗ |
| 2014-05-16 | NOVIELLI MICHAEL A | Director | S-Sale | D | Common Stock | 71,200 | 0.84 | 59.8K | 4,204,988 | — | ↗ |
| 2013-10-09 | NOVIELLI MICHAEL A | Director / 10% Owner | J-Other | A | Warrants | 8,333 | 0.60 | 5.0K | 8,333 | — | ↗ |
| 2013-10-09 | LEIGHTON DOUGLAS | Director / 10% Owner | J-Other | A | Warrants | 8,333 | 0.60 | 5.0K | 8,333 | — | ↗ |
| 2013-10-01 | NOVIELLI MICHAEL A | Director / 10% Owner | J-Other | A | Common Stock | 800,000 | 0.56 | 448.0K | 2,800,004 | — | ↗ |
| 2013-07-25 | NOVIELLI MICHAEL A | Director / 10% Owner | J-Other | A | Common Stock | 1,950,260 | 0.00 | — | 2,000,004 | — | ↗ |
| 2013-07-25 | LEIGHTON DOUGLAS | Director / 10% Owner | J-Other | A | Common Stock | 1,950,260 | 0.00 | — | 0 | — | ↗ |
| 2013-05-14 | NOVIELLI MICHAEL A | Director / 10% Owner | J-Other | D | Series C Convertible Preferred Stock | 75 | 0.00 | — | 0 | — | ↗ |
| 2013-05-14 | LEIGHTON DOUGLAS | Director / 10% Owner | J-Other | D | Series C Convertible Preferred Stock | 75 | 0.00 | — | 0 | — | ↗ |
| 2013-03-22 | NOVIELLI MICHAEL A | Director / 10% Owner | P-Purchase | A | Series H Convertible Preferred Stock | 500 | 0.30 | 150.00 | 500 | — | ↗ |
| 2013-03-22 | LEIGHTON DOUGLAS | Director / 10% Owner | P-Purchase | A | Series H Convertible Preferred Stock | 2,000 | 0.30 | 600.00 | 2,000 | — | ↗ |
| 2013-03-11 | NOVIELLI MICHAEL A | Director / 10% Owner | J-Other | A | Common Stock | 4,152,295 | 0.00 | — | 420,152,295 | — | ↗ |
| 2013-03-11 | LEIGHTON DOUGLAS | Director | J-Other | D | Series G Convertible Preferred Stock | 195,026 | 0.00 | — | 0 | — | ↗ |
| 2009-09-08 | Yan Jiuding | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-09-08 | Wang Zhongmin | Director | A-Award | A | Options (Right to Buy) | 20,000 | 1.60 | 32.0K | 20,000 | — | ↗ |
| 2009-09-08 | MacLean John Coleman | Director | A-Award | A | Options (Right to Buy) | 20,000 | 1.60 | 32.0K | 20,000 | — | ↗ |
| 2009-09-08 | Jin Lesley | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2009-08-10 | Wang Jianxin | Director | A-Award | A | Options (Right to Buy) | 20,000 | 1.60 | 32.0K | 20,000 | — | ↗ |
| 2009-08-10 | Ching Mia Kuang | Director | A-Award | A | Options (Right to Buy) | 20,000 | 1.60 | 32.0K | 20,000 | — | ↗ |
| 2009-06-17 | LIHUA WANG | Director / Officer | S-Sale | D | Common Stock | 188,109 | 37,621.00 | 7.08B | 3,810,178 | — | ↗ |
| 2009-06-17 | LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTD | 10% Owner | S-Sale | D | Common Stock | 940,541 | 188,108.00 | 176.92B | 19,050,888 | — | ↗ |
| 2009-06-17 | GANG LI | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 752,432 | 150,486.00 | 113.23B | 15,240,710 | — | ↗ |
| 2009-05-28 | LIHUA WANG | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,164,000 | 232,800.00 | 270.98B | 3,998,286 | — | ↗ |
| 2009-05-28 | LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTD | 10% Owner | S-Sale | D | Common Stock | 5,820,000 | 1,164,000.00 | 6.77T | 19,991,429 | — | ↗ |
| 2009-05-28 | GANG LI | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,656,000 | 931,200.00 | 4.34T | 15,993,143 | — | ↗ |
| 2008-01-10 | LIHUA WANG | Director / Officer / 10% Owner | P-Purchase | D | Common Stock | 5,162,286 | 270,445.72 | 1.40T | 5,162,286 | — | ↗ |
| 2008-01-10 | LIAONING NENGFA WEIYE NEW ENERGY APPLICATION CO LTD | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 25,811,429 | — | ↗ |
| 2008-01-10 | GANG LI | Director / Officer / 10% Owner | P-Purchase | D | Common Stock | 20,649,143 | 1,081,782.86 | 22.34T | 20,649,143 | — | ↗ |
| 2006-01-11 | Wyler Scott | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,400,000 | — | ↗ |
| 2006-01-11 | Dawley Robert | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 2,000,000 | — | ↗ |
| 2006-01-06 | Magdovitz Bernard | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 200,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-61.5K
Shares Outstanding
11.56M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2022 | Tiewei Song (CEO, Director) | 825.0K | — | 92.3K | — | — | — | 917.3K | 10.06% | ↗ |
| 2 | 2022 | Xiaoping Wang (COO) | 500.0K | — | 61.5K | — | — | — | 561.5K | 10.95% | ↗ |
| 3 | 2022 | Baiqun Zhong (CFO) | 104.2K | — | — | — | — | — | 104.2K | 0.00% | ↗ |
| 4 | 2021 | Tiewei Song (CEO, Director) | 625.0K | — | 235.0K | — | — | — | 860.0K | 27.33% | ↗ |
| 5 | 2021 | Baiqun Zhong (CFO) | 145.8K | — | — | — | — | — | 145.8K | 0.00% | ↗ |
| 6 | 2020 | Tiewei Song (CEO, Director) | 500.0K | — | — | — | — | — | 500.0K | 0.00% | ↗ |
| 7 | 2019 | Tiewei Song Chief Executive Officer and Director | 124.9K | — | — | — | — | — | 124.9K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tiewei Song | Chief Executive Officer & Director | 825.0K | male |
| Xiaoping Wang | Chief Operating Officer | 500.0K | male |
| Baiqun Zhong | Interim Chief Financial Officer | 104.2K | female |
| Fnu Oudom | Chairman of Board & President | — | male |
ESG Rating
ESG Score History MEDICAL - PHARMACEUTICALS
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BIMI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
